Ramazan Idilman; Mehmet Demir; Murat Aladag; Cihan Erol; Bilger Cavus; Raim Iliaz; Hayrettin Koklu; Yilmaz Cakaloglu; Memduh Sahin; Galip Ersoz; Iftihar Koksal; Zeki Karasu; Meric Ozgenel; Ilker Turan; Feyza Gunduz; Huseyin Ataseven; Meral Akdogan; Murat Kiyici; Köksal, Aydın Şeref; Sila Akhan; Fulya Gunsar; Fehmi Tabak; Sabahattin Kaymakoglu; Ulus S. Akarca; Mesut Akarsu; Huseyin Alkim; Filiz Araz; Fehmi Ates; Bilgehan Aygen; Ismail Balik; Huseyin S. Barut; Birol Baysal; Aylin Bolat; Ilhami Celik; Suleyman Cosgun; Fatih Ensaroglu; Hale Gokcan; Selim Gurel; Sebnem Gursoy; Ahmet Cagan Inkaya; Cemil Kamilli; Taylan Kav; Ziya Kuruuzum; Fatih O. Onder; Necati Ormeci; Omer Ozbakir; Seren Ozenirler; Birol Ozer; Hasan Ozkan; Sule Poturoglu; Ebubekir Senates; Halis Simsek; Toka, Bilal; Hakan Unal; Serkan Yaras; Abdullah E. Yildirim; Beytullah Yildirim; Bulent Yilmaz; Hasan Yilmaz; Ahmet Yozgat; Cihan Yurdaydin
(WILEY, 2019)
Ledipasvir and sofosbuvir with or without ribavirin is an effective and tolerable treatment in hepatitis C virus-infected patients with advanced liver disease. Eradication is associated with improvements in liver function ...
